The CD25-binding antibody Daclizumab High-Yield Process has a distinct glycosylation pattern and reduced antibody-dependent cell-mediated cytotoxicity in comparison to Zenapax®

od Ganguly, Bishu, Balasa, Balaji, Efros, Lyubov, Hinton, Paul R., Hartman, Stephen, Thakur, Archana, Xiong, Joanna M., Schmidt, Brian, Robinson, Randy R., Sornasse, Thierry, Vexler, Vladimir, Sheridan, James P.
Wydane w MAbs (2016)

Target-mediated drug disposition and prolonged liver accumulation of a novel humanized anti-CD81 monoclonal antibody in cynomolgus monkeys

od Vexler, Vladimir, Yu, Li, Pamulapati, Chandrasena, Garrido, Rosario, Grimm, Hans Peter, Sriraman, Priya, Bohini, Sandhya, Schraeml, Michael, Singh, Usha, Brandt, Michael, Ries, Stefan, Ma, Han, Klumpp, Klaus, Ji, Changhua
Wydane 2013

PDL241, a novel humanized monoclonal antibody, reveals CD319 as a therapeutic target for rheumatoid arthritis

od Woo, Jacky, Vierboom, Michel PM, Kwon, Hakju, Chao, Debra, Ye, Shiming, Li, Jianmin, Lin, Karen, Tang, Irene, Belmar, Nicole A, Hartman, Taymar, Breedveld, Elia, Vexler, Vladimir, ‘t Hart, Bert A, Law, Debbie A, Starling, Gary C
Wydane 2013

CS1, a Potential New Therapeutic Antibody Target for the Treatment of Multiple Myeloma

od Hsi, Eric D., Steinle, Roxanne, Balasa, Balaji, Szmania, Susann, Draksharapu, Aparna, Shum, Benny P., Huseni, Mahrukh, Powers, David, Nanisetti, Amulya, Zhang, Yin, Rice, Audie G., van Abbema, Anne, Wong, Melanie, Liu, Gao, Zhan, Fenghuang, Dillon, Myles, Chen, Shihao, Rhodes, Susan, Fuh, Franklin, Tsurushita, Naoya, Kumar, Shankar, Vexler, Vladimir, Shaughnessy, John D., Barlogie, Bart, van Rhee, Frits, Hussein, Mohamad, Afar, Daniel E.H., Williams, Marna B.
Wydane w Clin Cancer Res (2008)